Trending Topics
Sensex Live
Gold Silver Price Today
Petrol Diesel Prices Today
LPG Gas Cylinder Rate
CMPDI IPO

Ranbaxy shares end down 7% as Mylan sues FDA to block Lipitor launch

Ranbaxy shares plunged 7% to close at Rs 435.95 Monday after US company Mylan Inc sued the US Foods and Drug Administration for an injunction on the launch of Ranbaxy’s cholesterol treatment drug, Atorvastatin, which is a generic version of Pfizer’s Lipitor.

March 21, 2011 / 18:45 IST
Story continues below Advertisement
Remove Ad

Ranbaxy shares plunged 7% to close at Rs 435.95 Monday after US company Mylan Inc sued the US Foods and Drug Administration for an injunction on the launch of Ranbaxy

first published: Mar 21, 2011 06:30 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Iran War News Live Gold Silver Rate Today Petrol Diesel Prices IDBI Bank Share Price Hyderabad Farmhouse raid Rajya Sabha Elections Mutual Fund Ratios Donald Trump LPG Rate
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds Silver MCX Price Gold MCX Price
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.